Firalis Molecular Precision is a one-stop-shop for biomarker R&D programs. Dedicated to academic institutes and biopharmaceutical companies, our end-to-end platform for multi-omics biomarker discovery and validation to assay development and manufacturing offers a complete support from research/clinical study design to IVD kits regulatory approval.
Our value offer is based on high customizable, flexible and qualitative services to extract the best outcomes from your clinical samples in 3 main therapeutic areas: Neurology, Cardiology and Oncology.
Firalis Molecular Precision also leads proprietary programs to develop cutting-edge CE-marked long non-coding RNA-based in vitro diagnostic kits in Neurology (Neurolincs) and Cardiology (Fimics).
Feb 26, 2023
Posted by Firalis Molecular Precision